Personal choice. The 2.8c goes straight to the company to progress the pipeline, which in turn will grow the market cap/share price.
The 2.6c goves more bang for the buck. But if the pipeline isnt fully funded, its development will be delayed, so slower growth potential.
Both concepts have pros and cons.
- Forums
- ASX - By Stock
- Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial
CHM
chimeric therapeutics limited
Add to My Watchlist
33.3%
!
0.4¢

Personal choice. The 2.8c goes straight to the company to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $12.99M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $949 | 312.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
70 | 67782438 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 91927011 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
70 | 67782438 | 0.003 |
26 | 26746044 | 0.002 |
13 | 54414000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 91927011 | 27 |
0.005 | 33248062 | 21 |
0.006 | 17929018 | 21 |
0.007 | 6512518 | 7 |
0.008 | 7317101 | 5 |
Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |